Cash from operations positive
Research tool · not investment advice. Full disclaimer →
Cash from operations positive
The business brought in more cash than it spent running itself, over the latest filed year.
as of 2026-06-30, evening checks after 20:00 IST · Cash from Operating Activity > 0 (latest filed FY), NSE XBRL filings only
966 names — the whole scan, sortable and cuttable below
Honest boundaryA scan describes what a stock has already done, measured against its own history; membership of this list is a description, never an entry · descriptive, not a signal.
| Symbol | Financial year | Cash from ops | Capex | Free cash flow🔴 Both legs must be filed. Cash from operations minus capital expenditure. A missing capex line is a filer that did not tag it, never a company that spent nothing — coercing it to zero would report such a name as maximally cash-generative, the direction an error must never take. Lenders are absent by construction: a bank files no capital-expenditure tag at all, so free cash flow is uncomputable for one rather than zero. | FCF % of sales | Net profit | Rank in scan |
|---|---|---|---|---|---|---|---|
| GLENMARK | 2026-03-31 | 3,445 Cr | 1,358 Cr | 2,087 Cr | 12.3% | 1,362 Cr | #51 |
| WELCORP | 2026-03-31 | 3,204 Cr | 2,532 Cr | 672 Cr | 4.0% | 1,620 Cr | #52 |
| MANKIND | 2026-03-31 | 3,121 Cr | 626 Cr | 2,495 Cr | 17.5% | 1,938 Cr | #53 |
| TORNTPHARM | 2026-03-31 | 3,023 Cr | 677 Cr | 2,346 Cr | 16.8% | 2,138 Cr | #54 |
| APOLLOHOSP | 2026-03-31 | 2,856 Cr | 1,962 Cr | 894 Cr | 3.5% | 2,003 Cr | #55 |
| GESHIP | 2026-03-31 | 2,854 Cr | 2,372 Cr | 481 Cr | 8.9% | 2,943 Cr | #56 |
| PIDILITIND | 2026-03-31 | 2,829 Cr | 593 Cr | 2,237 Cr | 15.3% | 2,471 Cr | #57 |
| RPOWER | 2026-03-31 | 2,824 Cr | 116 Cr | 2,708 Cr | 35.5% | -337 Cr | #58 |
| DIVISLAB | 2026-03-31 | 2,738 Cr | 2,520 Cr | 218 Cr | 2.1% | 2,568 Cr | #59 |
| OFSS | 2026-03-31 | 2,638 Cr | 52 Cr | 2,587 Cr | 33.7% | 2,639 Cr | #60 |
| BRITANNIA | 2026-03-31 | 2,612 Cr | 206 Cr | 2,406 Cr | 12.6% | 2,537 Cr | #61 |
| DABUR | 2026-03-31 | 2,579 Cr | 420 Cr | 2,158 Cr | 16.4% | 1,869 Cr | #62 |
| SRF | 2026-03-31 | 2,554 Cr | 1,815 Cr | 738 Cr | 4.7% | 1,835 Cr | #63 |
| GODREJCP | 2026-03-31 | 2,488 Cr | 570 Cr | 1,919 Cr | 12.6% | 1,861 Cr | #64 |
| INDHOTEL | 2026-03-31 | 2,471 Cr | 1,037 Cr | 1,435 Cr | 14.8% | 2,247 Cr | #65 |
| PHOENIXLTD | 2026-03-31 | 2,426 Cr | 1,397 Cr | 1,029 Cr | 23.3% | 1,557 Cr | #66 |
| TATACONSUM | 2026-03-31 | 2,422 Cr | 449 Cr | 1,973 Cr | 9.7% | 1,547 Cr | #67 |
| EXIDEIND | 2026-03-31 | 2,413 Cr | 1,153 Cr | 1,261 Cr | 7.0% | 860 Cr | #68 |
| NTPCGREEN | 2026-03-31 | 2,386 Cr | 15,264 Cr | -12,878 Cr | -450.5% | 521 Cr | #69 |
| NAVA | 2026-03-31 | 2,312 Cr | 1,807 Cr | 505 Cr | 11.8% | 1,039 Cr | #70 |
| DALBHARAT | 2026-03-31 | 2,278 Cr | 2,056 Cr | 222 Cr | 1.5% | 1,157 Cr | #71 |
| BALKRISIND | 2026-03-31 | 2,249 Cr | 3,003 Cr | -754 Cr | -7.0% | 1,243 Cr | #72 |
| BOSCHLTD | 2026-03-31 | 2,175 Cr | 316 Cr | 1,859 Cr | 9.3% | 2,773 Cr | #73 |
| PVRINOX | 2026-03-31 | 2,160 Cr | 259 Cr | 1,902 Cr | 28.6% | 333 Cr | #74 |
| ZYDUSLIFE | 2026-03-31 | 2,117 Cr | 3,394 Cr | -1,277 Cr | -4.7% | 5,124 Cr | #75 |
| APLAPOLLO | 2026-03-31 | 2,103 Cr | 696 Cr | 1,407 Cr | 6.1% | 1,203 Cr | #76 |
| MARICO | 2026-03-31 | 2,084 Cr | 319 Cr | 1,765 Cr | 13.0% | 1,813 Cr | #77 |
| AEGISLOG | 2026-03-31 | 2,028 Cr | 821 Cr | 1,207 Cr | 14.5% | 1,107 Cr | #78 |
| JSWINFRA | 2026-03-31 | 2,022 Cr | 2,492 Cr | -470 Cr | -8.8% | 1,547 Cr | #79 |
| ALKEM | 2026-03-31 | 1,963 Cr | 617 Cr | 1,346 Cr | 9.1% | 2,351 Cr | #80 |
| JUBLFOOD | 2026-03-31 | 1,894 Cr | 999 Cr | 895 Cr | 9.4% | 444 Cr | #81 |
| JKCEMENT | 2026-03-31 | 1,873 Cr | 2,416 Cr | -543 Cr | -4.0% | 988 Cr | #82 |
| ENDURANCE | 2026-03-31 | 1,851 Cr | 1,296 Cr | 555 Cr | 3.8% | 952 Cr | #83 |
| COLPAL | 2026-03-31 | 1,806 Cr | 76 Cr | 1,730 Cr | 28.7% | 1,325 Cr | #84 |
| SUNTV | 2026-03-31 | 1,802 Cr | 84 Cr | 1,718 Cr | 39.6% | 1,441 Cr | #85 |
| CEATLTD | 2026-03-31 | 1,786 Cr | 2,267 Cr | -481 Cr | -3.1% | 697 Cr | #86 |
| DIXON | 2026-03-31 | 1,782 Cr | 1,068 Cr | 715 Cr | 1.5% | 1,644 Cr | #87 |
| JINDALSAW | 2026-03-31 | 1,771 Cr | 1,076 Cr | 695 Cr | 3.9% | 925 Cr | #88 |
| NATCOPHARM | 2026-03-31 | 1,768 Cr | 388 Cr | 1,380 Cr | 33.8% | 1,418 Cr | #89 |
| PERSISTENT | 2026-03-31 | 1,767 Cr | -13 Cr | 1,781 Cr | 12.1% | 1,865 Cr | #90 |
| HEXT | 2025-12-31 | 1,739 Cr | 168 Cr | 1,572 Cr | 11.7% | 1,368 Cr | #91 |
| SARDAEN | 2026-03-31 | 1,735 Cr | 338 Cr | 1,397 Cr | 24.6% | 1,109 Cr | #92 |
| CUMMINSIND | 2026-03-31 | 1,734 Cr | 252 Cr | 1,483 Cr | 12.2% | 2,362 Cr | #93 |
| WEWORK | 2026-03-31 | 1,734 Cr | 456 Cr | 1,278 Cr | 52.4% | 75 Cr | #94 |
| CLEANMAX | 2026-03-31 | 1,731 Cr | 5,687 Cr | -3,956 Cr | -206.8% | 86 Cr | #95 |
| LGEINDIA | 2026-03-31 | 1,721 Cr | 1,172 Cr | 549 Cr | 2.2% | 1,685 Cr | #96 |
| UNOMINDA | 2026-03-31 | 1,720 Cr | 1,572 Cr | 148 Cr | 0.8% | 1,284 Cr | #97 |
| LENSKART | 2026-03-31 | 1,670 Cr | 828 Cr | 841 Cr | 9.5% | 501 Cr | #98 |
| PPLPHARMA | 2026-03-31 | 1,653 Cr | 890 Cr | 763 Cr | 8.6% | -326 Cr | #99 |
| MAXHEALTH | 2026-03-31 | 1,633 Cr | 1,485 Cr | 149 Cr | 1.8% | 1,442 Cr | #100 |